Ainnocence

3个月前更新 8 0 0
收藏 0

Simplicity Constitutes Supreme Excellence Ainnocence is a global AI Biotech company leading virtual screening, scientific intelligence, and molecular generative AI. Log I...

所在地：
美国
收录时间：
2024-12-13
打开网站
AinnocenceAinnocence
Ainnocence
Ainnocence is a next-generation biotech company that integrates AI and computational biology to accelerate drug discovery and development. Founded by a team of biomedical scientists and computer scientists, Ainnocence offers a self-evolving AI platform for designing small and large molecules, significantly reducing the costs and risks associated with drug discovery.
Key features include:
  • SentinusAI™: A de novo antibody and fusion protein engineering engine that performs antibody design and optimization based on sequences. It can mature protein-protein binding affinity, humanize proteins, predict off-target toxicity, and evaluate protein stability.
  • CarbonAI™: A de novo small-molecule and PROTAC design engine for multi-objective pharmacological profile optimization. It optimizes target binding, generates molecules, evaluates ADME and PK properties, and predicts off-target effects.
  • InnocentAI™ Platform: A self-evolving AI cloud platform that runs on AWS, supporting multiple drug-design AI modules with unlimited scalability. The platform can screen up to 10^10 protein sequences or chemical compounds within hours, delivering highly optimized drug candidates with a high wet-lab hit rate.
Ainnocence is ideal for biotech and pharmaceutical companies aiming to develop preclinical drug candidates through AI-driven virtual screening and optimization.
打赏微海报分享

数据统计

相关导航

暂无评论

none
暂无评论...